ACHV Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ACHV shares is 88, representing 59.62% of the company's common stock.

RENAISSANCE TECHNOLOGIES LLC, in the last quarter, reduced its stake in ACHV by -29.99% restricting it's holding to 499.23 thousand shares of worth nearly $198.00K. BANK OF AMERICA CORP /DE/ also lessened -100% of the ACHV shares from its portfolio, reducing its holding to 0 shares of worth -. BARCLAYS PLC also shunned ACHV shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, CORNERSTONE PLANNING GROUP LLC increased its stake in ACHV by 100% in the last quarter. The institutional holder raised its holding to 100 shares having worth more than $412.00. REQUISITE CAPITAL MANAGEMENT, LLC also added 100% more shares of ACHV to its portfolio, raising its holding to 1 million shares of worth $397.00K. UBS GROUP AG also increased its ACHV shares holding by 16.99% which brought its holding to 91.95 thousand shares worth $37.00K.

The insider with the most stakes in ACHV is ARMISTICE CAPITAL, LLC , 10 percent owner at the company. Additionally, ACHV stock is highly held by 10 percent owner H.I.G. ONCOGENEX, INC. and President and CEO Cormack Scott Daniel among others.

Company executives, directors, and other insiders own 9.72% percent of Achieve Life Sciences, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ACHV insiders have sold stock, totaling 0 shares. Insiders that have sold shares include ARMISTICE CAPITAL, LLC, BENCICH JOHN, and CORMACK SCOTT DANIEL.

There have been 0 transaction(s) during the past 6-months in which Achieve Life Sciences, Inc. insiders have bought stock, totalling 0 shares

Around 0 Achieve Life Sciences, Inc. shares are held by insiders, which represents about 9.72% of ACHV stock.

ACHV 10 percent owner, ARMISTICE CAPITAL, LLC holds the largest portfolio of the company's shares. ACHV shares owned by ARMISTICE total nearly 843.78 thousand.

CORNERSTONE PLANNING GROUP LLC is the largest institutional owner in ACHV which holds 100 shares worth $412.00 or 0% of the total ACHV shares outstanding followed by PURA VIDA INVESTMENTS, LLC with ownership of 1.33 million shares representing 3.82% of the ACHV ownership. REQUISITE CAPITAL MANAGEMENT, LLC is the third largest stakeholder with 1 million shares or 2.87% of the ownership worth more than $397.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ACHV is concerned, it is a stock which is optionable.

Number of ACHV shares short is 3.81M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 34.39M shares of ACHV are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ACHV has 32.58M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ACHV is 24.87.